Literature DB >> 16423603

Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in Northwest England.

Leena Patel1, Richard J Q McNally, Elizabeth Harrison, I Christopher Lloyd, Peter E Clayton.   

Abstract

OBJECTIVE: To study the distribution of septo-optic dysplasia (SOD) and optic nerve hypoplasia (ONH) in the Greater Manchester and Lancashire (GM&L) region of Northwest England, and to analyze occurrence by location and over time. STUDY
DESIGN: A population-based incidence study was undertaken for cases of SOD/ONH from GM&L. Standardized incidence ratio (SIR) for each district, relationships between SIRs and possible geographically varying risk factors, and spatial and space-time clustering were analyzed.
RESULTS: Eighty-seven cases had a confirmed diagnosis of ONH/SOD giving an incidence of 10.9/100,000 per year in GM&L. SIRs ranged widely but were significantly elevated (lower confidence limit >100) in three districts: 167%, 192%, and 198%, respectively. All three were high population density, inner-city locations. SIRs were significantly correlated with higher rates of unemployment (r = 0.49, P = .01), dependent children in non-earning households (r = 0.47, P = .02), underage conceptions (r = 0.46, P = .02), and underage pregnancies (r = 0.44, P = .03). There was no evidence of spatial or space-time clustering.
CONCLUSIONS: The incidence of ONH/SOD in GM&L was higher than that reported elsewhere. Cases were more common in areas that had higher unemployment and teenage pregnancy rates.

Entities:  

Mesh:

Year:  2006        PMID: 16423603     DOI: 10.1016/j.jpeds.2005.07.031

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  51 in total

1.  Outcome of fetuses with cerebral ventriculomegaly and septum pellucidum leaflet abnormalities.

Authors:  Yi Li; Rakhee K Sansgiri; Judy A Estroff; Tejas S Mehta; Tina Y Poussaint; Richard L Robertson; Caroline D Robson; Henry A Feldman; Carol Barnewolt; Deborah Levine
Journal:  AJR Am J Roentgenol       Date:  2011-01       Impact factor: 3.959

Review 2.  Prenatal determinants of optic nerve hypoplasia: review of suggested correlates and future focus.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Surv Ophthalmol       Date:  2013 Nov-Dec       Impact factor: 6.048

Review 3.  Septo-optic dysplasia.

Authors:  Emma A Webb; Mehul T Dattani
Journal:  Eur J Hum Genet       Date:  2009-07-22       Impact factor: 4.246

Review 4.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

Review 5.  Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.

Authors:  S W Davis; F Castinetti; L R Carvalho; B S Ellsworth; M A Potok; R H Lyons; M L Brinkmeier; L T Raetzman; P Carninci; A H Mortensen; Y Hayashizaki; I J P Arnhold; B B Mendonça; T Brue; S A Camper
Journal:  Mol Cell Endocrinol       Date:  2009-12-16       Impact factor: 4.102

6.  Incidental bilateral optic nerve hypoplasia.

Authors:  Joshua Paul Harvey
Journal:  BMJ Case Rep       Date:  2017-06-13

7.  Optic nerve hypoplasia syndrome: a review of the epidemiology and clinical associations.

Authors:  Pamela Garcia-Filion; Mark Borchert
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

8.  Absence of age-related optic disk changes in young children with optic nerve hypoplasia.

Authors:  J Sutedja; P Garcia-Filion; C Fink; M Borchert
Journal:  Eye (Lond)       Date:  2014-02-21       Impact factor: 3.775

9.  Optic nerve hypoplasia in North America: a re-appraisal of perinatal risk factors.

Authors:  Pamela Garcia-Filion; Cassandra Fink; Mitchell E Geffner; Mark Borchert
Journal:  Acta Ophthalmol       Date:  2008-12-24       Impact factor: 3.761

Review 10.  Congenital abnormalities of the optic nerve: from gene mutation to clinical expression.

Authors:  Palak B Wall; Elias I Traboulsi
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.